文献速递免疫规划卫生政策与健康促进

阿尔巴尼亚医护人员流感疫苗接种项目成本分析

Program cost analysis of influenza vaccination of health care workers in Albania.
PubMed 文献 · Vaccine · 2019-10-25

该研究采用世界卫生组织季节性流感免疫成本核算工具(SIICT)的微观成本法,从政府视角估算阿尔巴尼亚2018-19季节医护人员接种三价灭活流感疫苗的增量成本。基线情景下13,377名医护人员(占符合条件者的70%)接种,增量财务成本为61,296美元,经济成本为161,639美元。结论认为成本估算有助于为扩大医护人员及其他风险人群流感疫苗接种的决策提供依据。

要点

  • 基线情景下13,377名医护人员(占符合条件者的70%)接种,增量财务成本61,296美元,经济成本161,639美元。
  • 疫苗和接种用品占财务成本的最大份额(89%),占经济成本的44%。
  • 每名接种医护人员的财务成本为4.58美元,经济成本为12.08美元(含疫苗和接种用品)。

核心结论

  • 成本估算有助于为扩大医护人员及其他风险人群流感疫苗接种的决策提供依据。

研究设计与样本

  • 采用世界卫生组织季节性流感免疫成本核算工具(SIICT)的微观成本法,从政府视角估算阿尔巴尼亚2018-19季节医护人员接种三价灭活流感疫苗的增量成本,基于2016-17季节的行政记录、关键知情人咨询和便利抽样现场访视数据。

主要发现

  • 基线情景下,13,377名医护人员(占符合条件医护人员的70%)将接种疫苗,增量财务成本为61,296美元,经济成本为161,639美元。
  • 疫苗和接种用品占财务成本的最大份额(89%),占经济成本的44%。
  • 每名接种医护人员的财务成本为4.58美元,经济成本为12.08美元(含疫苗和接种用品);不含疫苗和接种用品时分别为0.49美元和6.76美元。
  • 提高覆盖率、使用预充式注射器及提高疫苗价格的情景均增加总经济成本和财务成本,但每名接种医护人员的经济成本随覆盖率提高而下降,因部分成本分摊到更多医护人员。
  • 在所有情景中,经济成本占阿尔巴尼亚估计政府卫生支出的比例<0.07%,占估计免疫规划经济成本的比例<5.07%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Since 2012, WHO has recommended influenza vaccination for health care workers (HCWs), which has different costs than routine infant immunization; however, few cost estimates exist from low- and middle-income countries. Albania, a middle-income country, has self-procured influenza vaccine for some HCWs since 2014, supplemented by vaccine donations since 2016 through the Partnership for Influenza Vaccine Introduction (PIVI). We conducted a cost analysis of HCW influenza vaccination in Albania to inform scale-up and sustainability decisions. METHODS: We used the WHO's Seasonal Influenza Immunization Costing Tool (SIICT) micro-costing approach to estimate incremental costs from the government perspective of facility-based vaccination of HCWs in Albania with trivalent inactivated influenza vaccine for the 2018-19 season based on 2016-17 season data from administrative records, key informant consultations, and a convenience sample of site visits. Scenario analyses varied coverage, vaccine presentation, and vaccine prices. RESULTS: In the baseline scenario, 13,377 HCWs (70% of eligible HCWs) would be vaccinated at an incremental financial cost of US$61,296 and economic cost of US$161,639. Vaccine and vaccination supplies represented the largest share of financial (89%) and economic costs (44%). Per vaccinated HCW financial cost was US$4.58 and economic cost was US$12.08 including vaccine and vaccination supplies (US$0.49 and US$6.76 respectively without vaccine and vaccination supplies). Scenarios with higher coverage, pre-filled syringes, and higher vaccine prices increased total economic and financial costs, although the economic cost per HCW vaccinated decreased with higher coverage as some costs were spread over more HCWs. Across all scenarios, economic costs were <0.07% of Albania's estimated government health expenditure, and <5.07% of Albania's estimated immunization program economic costs. CONCLUSIONS: Cost estimates can help inform decisions about scaling up influenza vaccination for HCWs and other risk groups.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Pallas SW, Ahmeti A, Morgan W, et al. Program cost analysis of influenza vaccination of health care workers in Albania. Vaccine. 2019. PMID: 31669063. doi:10.1016/j.vaccine.2019.10.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。